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Redressing the Silent Interim: Precautionary




In 1990, the National Research Council (NRC), under the
authority of a United States congressional commission, began
investigating the methods that the Environmental Protection Agency
(EPA) uses to estimate toxicological risk. In its executive summary, the
NRC concluded that "because of limitations on time, resources,
scientific knowledge, and available data, EPA should generally retain its
conservative, default-based approach to risk assessment for screening
analysis in standard setting; however, several corrective actions are
needed to make this approach more effective."'
The two corrective areas the NRC recommends for incorporation
into EPA's traditional, default-based quantitative risk assessment
methodology are: (1) development of an iterative approach to risk
assessment, and (2) when reporting estimates of risk to decision-makers
and the public, it should present not just point estimates, but also
sources and magnitudes of uncertainty associated with such estimates.
In 1996, the NRC also stated the importance of understanding risk
characterization as both an analytical and participant-driven deliberative
process, which ought to be problem-driven, accountable to the role of
* This article was awarded First Place in the 2000 RISK Writing Competition. The author
wishes to thank the referees for their helpful comments, RISK for facilitating such a unique
opportunity for graduate students, and especially Dr. Tom LaPoint, Director of the Institute of
Applied Sciences at the University of North Texas for his invaluable guidance.
** Mr. Riley is a graduate student at the University of North Texas in the Department of
Philosophy, specializing in comparative risk analysis, primarily working with incorporating
precautionary action into quantitative ecological risk assessment and water resource
management. He graduated with honors with a dual B.A. in Political Science and Philosophy
from the University of North Texas. Mr. Riley works as the Environmental Compliance
Specialist for the City of Denton, Texas. E-maik Timothy.Riley@cityofdenton.com.
I Committee on Risk Assessment of Hazardous Air Pollutants, National Research Council,
Science and Judgment in Risk Assessment 14 (1994).
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uncertainty in risk management and broadly inclusive of potential
interest-holders.
2
In this paper, I argue for incorporating "non-traditional"
precautionary measures with the procedural recommendations of the
NRC into traditional toxicological risk assessment practices. Such
inclusion of a precautionary disposition is most critical during the
interim period of a toxicological risk assessment. Particularly in a post-
market regulatory situation, a potential toxicological hazard may have
been present in the environment and exposing human and animal
populations for a period of time, perhaps even years, before the hazard
was identified. Often, assessment of the potential danger and corrective
action, if necessary, must be initiated quickly after identification.
This raises an important technical, political, and ethical question:
Once a potential toxicological hazard has been identified, what actions
ought to be taken to ensure public health and ecological integrity?
Adherents of traditional toxicological risk assessment and advocates of
the Precautionary Principle both offer competing paradigms about how
to answer this question. In an attempt to combine elements from each
paradigm, I will address this question by focusing on the NRC's first
corrective area - the development of an iterative approach
methodology and discussion of the importance of using Short-Term
Tests (STTs) as precautionary indicators of possible toxicological
danger associated with potentially carcinogenic substances during the
interim phase of toxicological risk assessments.
An iterative approach to risk assessment supports the idea of initially
using less expensive and time consuming testing procedures that can
quickly isolate potentially harmful persistent toxic chemicals from
potentially harmless ones. The use of short-term tests, which are specific
testing procedures designed for inexpensive preliminary screening,
would streamline EPA and state regulatory action. In this manner,
STTs allow for sufficient resources to be used on a broader array of
possible potentially toxic substances by minimizing testing costs and
time and therein protecting the underlying normative assumption in
any toxicological risk assessment - minimizing the social costs in
reference to the potential risks of endangered public health and
2 Committee on Risk Characterization, National Research Council, Understanding Risk-
Informing Decisions in a Democratic Society 2-5 & 164-165 (1996).
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ecological integrity.
A Backlogged and Failing Regulatory System
Regarding the concerns of toxic emissions and carcinogen risk, in
1987, the Congressional Office of Technology Assessment reported
that federal regulatory standards had only identified a minority of
potential carcinogens.3 Over 80,000 chemicals were estimated to be
in use in the United States, with over 2,000 new ones introduced
annually. 4 Although few of these chemicals are likely to pose a
significant human or environmental health risk, we nevertheless know
little or nothing about their potential carcinogenic properties, in part
because of the time and expense of conducting toxicological risk
assessments. This sluggish pace of identification and, consequently,
regulation under current toxic control policies has stirred public
demand for reform of America's environmental management, of toxics,
as the current regulatory process is marred by the immense amount of
interim time necessary to complete a toxicological risk assessment. 5
Conceptualized as a necessary component for environmental decision-
making, toxicological risk assessment, through measurement, testing,
and mathematical or statistical models seeks to balance the degree of
risk permitted against the cost of risk reduction and other competing
factors. 6
The EPA toxicological risk assessment framework, which is
conceptually similar to the NRC framework for human health risk
assessments, 7 is divided into three phases: (1) problem formulation;
3 Congressional Office of Technology Assessment, OTA-BP-H-42, Identifying and
Regulating Carcinogens (1987).
4 Congressional Office of Technology Assessment, OTA-BP-ENV-166, U.S. Congress
Screening and Testing Chemicals in Commerce, Washington: Office of Technology
Assessment 126 (1995).
5 See David Roe, An Incentive Conscious Approach to Toxic Chemical Control, 3 Econ.
Dev. Q. 179 (1989).
6 See Christoph Remann-Surter, Involving Others: Towards an Ethical Concept of Risk, 9
Risk. Health, Safety & Environment 119 (1998) (critiquing this construction of risk
assessment); cf Kristin Shrader-Frechette, Scientific Method, Anti-Foundationalism and
Public Decisionmaking, 1 Risk. Health & Safety 23 (1990); Kristin Shrader-Frechette, How
Some Risk Frameworks Disenfranchise the Public, 8 Risk. Health, Safety & Environment 1
(1997); Kristin Shrader-Frechette, Perceived Risks Versus Actual Risks: Managing Hazards
Through Negotiation, I Risk. Health & Safety 341 (1990).
7 Risk Assessment Forum, Environmental Protection Agency, EPA/630/R-92/001,
Framework for Ecological Risk Assessment 3 (1992).
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(2) analysis; and (3) risk characterization. The interim can be
considered the "analysis phase" consisting of two activities -
characterization of exposure and characterization of ecological effects.
Once the preliminary characterization of exposure and effects are
completed, as well as examination of scientific data and data needs,
policy and regulatory issues, and site-specific factors to define the
feasibility, scope, and objectives for the toxicological assessment, the
time consuming process of collecting and analyzing the data begins.
As early as 1984, this regulatory system was failing. The National
Academy of Sciences (NAS) reported a significant lack of data on
health effects of most industrial chemical products. The NAS found
that 78% of chemicals in high-volume commercial use lacked
"minimal" toxicity testing. The Environmental Defense Fund in 1997
and EPA in 1998 noted that the situation was not improving. For the
3,000 high-production-volume chemicals (those with over one million
pounds in commerce), the studies concluded that: 93% lack some basic
chemical screening data; 43% have no basic toxicity data; and 51% of
chemicals on the Toxic Release Inventory lack basic toxicity
information (a large percentage of available information is based only
on acute toxicity). 8 Also, the congressional Office of Technology
Assessment acknowledged that federal regulatory agencies had
insufficiently analyzed fewer than a third of the known carcinogens
under each of their statutory mandates. Furthermore, the National
Toxicology Program lists 144 known carcinogens testing positive in one
or more animal bioassays, and 62 substances found positive in three or
four animal studies, yet approximately only 15% of each group had
been assessed by the EPA's Carcinogen Assessment Group by 1987.9
8 Joel Tickner & Carolyn Raffensperger, The Precautionary Principle in Action: A
Handbook 12 <http:llwww.sehn.orglrtfdocslhandbook-rtf.rtf> (accessed Feb. 2000). This
handbook was written for the Science and Environmental Health Network.
9 Carl F. Cranor, The Normative Nature of Risk Assessment: Features and Possibilities, 8
Risk. Health, Safety & Environment 123 (1997) (citing Congressional Office of Technology
Assessment, Identifying and Regulating Carcinogens 1 (1987)).
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Limitations of Traditional Toxicological Risk Assessment
Rarely, if ever, during the collection and analysis of data is
precautionary action taken. Traditionally, risk management follows risk
assessment, and never the two shall meet. Nevertheless, a key normative
aspect of toxicological risk assessment is that it is extremely difficult or
impossible to separate risk assessment from risk management.
10
To a certain extent, a degree of separation between assessment and
management is necessary and desirable because it encourages both
assessors and managers to make explicit, epistemic warrants for their
claims and thus make their conclusions and recommendations more
objective. 11 Yet taken too far, such a paradigm creates a vacuum of
accountability in part because many risk assessors ignore value
assumptions in their methodological judgments, leading to uninformed
and therefore faulty risk-management decisions. 1
2
Yet, the notorious Red Book, 13 produced by the NRC Committee
on the Institutional Means for Assessment of Risks to Public Health,
presents a conceptual model of risk assessment as an objective scientific
activity, distinct from risk management in its exclusion of ethical,
political, and institutional values. The Red Book states: "If risk
management considerations ... are seen to affect ... a risk assessment,
the credibility of the assessment ... can be compromised." 14 The
transition from data acquisition and analysis to policy implementations
can be exceedingly long because of the want to stave off action until
"decisive" confirmation of toxicological harm can be positively
ascertained. Considerable time is usually required in order for scientists
and risk assessors to generate "scientifically valid" data that can be
properly analyzed with minimum risk of inaccuracies. As with the
Toxic Substances Control Act (TSCA), this "good science" aspect of
10 Committee on the Institutional Means for Assessment of Risks to Public Health, National
Research Council, Risk Assessment in the Federal Government: Managing the Process 76
(1 983) (hereinafter "Redbook").
11 Kristin Shrader-Frechette, Risk and Rationality 43-44 (U. of Cal. Press 1991).
12 Kristin Shrader-Frechette, Evaluating the Expertise of Experts, 6 Risk. Health, Safety &
Environment 115, 116 (citing Ellen Silbergeld, Risk Assessment and Risk Management: An
Uneasy Divorce, in Acceptable Evidence: Science and Values in Risk Management 107
(Deborah G. Mayo & Rachelle D. Hollander eds., 1991); Richard M. Sedman & Paul W.
Hadley, Comment, Risk Assessment and Risk Management: Mending the Schism, 3 Risk:
Health & Safety 189 (1992)).
13 See supra n. 10.
14 Redbook, supra n. 10, at 152.
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toxicological risk assessment, without considering the normative social
costs of its methodological paradigm, has left the world literally
flooded with thousands of potentially toxic substances, many of which
society is not even aware of because the screening system is so
backlogged and inefficient.
The presumption that risk assessment can be free of normative
assumptions is now a debunked modus operandi. 15 Social costs are
intricately bound to the procedural and scientific costs associated with
conducting toxicological risk assessments, and thus, normative
presuppositions must be considered in articulating methodological data
endpoints, as well as policy implications derived from those endpoints.
Furthermore, the last three decades have seen much progress in
exploring and revealing the interconnections between ecosystem
integrity, public health, and economic development. Using risk analysis
as one mechanism for determining the "certainty" of a potential
toxicological hazard requires more than merely a quantitative analysis.
Also required is an understanding of the concepts of equity and
fairness, the nature of cumulative risk, redefined notions of time frames
for the persistence of chemicals, and an appreciation for market
mechanisms such as incentives, cost-benefit analysis, and voluntary
initiatives. 16
Toxicological risk assessments are intrinsically pervaded with
uncertainties, some of which can be accounted for and quantified,
although others are pervasively indefinable (at least in a predictive
schema). 17 Quantification and qualification of "risk" entails
incorporating uncertainty as an operative component of our limited
ability to understand causal pathways of toxicological fates, especially
at the intersection of ecological integrity and public health. Absent
perfect procedures, the alternative is to use processes that minimize
resulting mistakes.
Carl Cranor argues that because of the prohibitive time and
financial costs of properly conducting a toxicological risk assessment,
15 \William Ruckelshaus, Risk, Science and Democracy, I Issues in Sci. and Tech. 19 (1985).
16 Michael D. Mehta, Risk Assessment and Sustainable Development: Towards a Concept
of Sustainable Risk, 8 Risk. Health, Safety & Environment 137, 154 (1997).
17 Tickner & Raffensperger, supra n. 8, at 11.
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there is a normative imperative to seek out alternative methodologies
that reduce overall costs and time.18 This suggests the existence of an
imperative to locate the minimum kind and amount of evidence
necessary to judge the toxicity of substances to serve relevant social
goals.
There can be significant social costs from slow risk assessments
when environmental assessors and managers operate under the
traditional risk assessment paradigm. On one hand, regulatory action
initiated after a potentially toxic or carcinogenic chemical is released
risks unnecessary toxic exposure until the chemical's toxicity is
discovered and regulated. On the other hand, the costs from slow
procedures themselves and opportunity costs resulting from the slow
rate of assessment may leave unevaluated other toxic substances in
commerce that could inflict serious injuries to public health and the
environment. Inaction, too, can be costly. The inherent slowness of risk
assessments, coupled with regulatory inertia, can keep possible life-
saving and/or ecologically benign substances from reaching
marketplaces. 19
Limitations of the Precautionary Principle
Precautionary Principle 20 adherents are concerned that risk
assessments provide a false sense of security manifested in a milieu of
quantitative, technical sophistication, while masking the inexact,
assumption-laden, and at times, politically and economically driven
science. Also, the burden-of-proof structure constituting the standards
for scientifically rigorous conclusions facilitates a continuation of
possibly greater pollution and degradation of public health under the
premise that it is either safe or presents an acceptable risk. Critics of
such a conceptual model argue that the separation of risk assessment
and risk management, although superficially appealing, is an inadequate
model for resolving complex social, political, and scientific problems
that are uniquely bound in the problem formulation and risk
characterization of a potentially carcinogenic substance. Citing several
18 See Cranor, supra n. 9.
19 Id.
20 See Protecting Public Health and the Environment: Implementing the Precautionary
Principle (Carolyn Raffensperger & Joel Tickner eds., 1999). This is an outstanding account of
the Precautionary Principle.
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previous works, Brown and Goble note that some argue that it would
make "the field too sterile and routine and stifle the creative impulses
of its practitioners, that it would result in addressing the wrong societal
problems and thus be irrelevant, and it would be inappropriate on
technical grounds."2 1 Advocates of the Precautionary Principle desire
the explicit reincorporation of normative assumptions into the
environmental regulatory schema.
The Precautionary Principle originates from Germany as the
Vorsorgeprinzip, or "principle of foresight." A fundamental aspect of
the Precautionary Principle is that precautionary action ought to be
taken before scientific certainty of cause and effect can be
ascertained.22 In recent years, the Precautionary Principle has figured
prominently and contentiously in many international statements of
policy, conventions, and national policies for sustainable development
and environmental protection. At the heart of the debate lies one of the
early tenants of the principle - the belief that society should in all its
endeavors avoid environmental damage by careful forward-thinking
planning and the elimination of dangerous levels of toxic chemicals.
23
Although this is not a new idea, during the interim phase of a risk
assessment, it is a rarity. In fact, even advocates of the Precautionary
Principle are primarily interested in imposing preventive action at the
"design stage of a potentially hazardous activity to ensure their greatest
impact."24 Some precautionary actions that can be initiated during the
21 Halina Szejnwald Brown & Robert L. Goble, The Role of Scientists in Risk Assessment, 1
Risk. Health & Safety 283, 285 (1990) (citing Dale Hattis & David Kennedy, Assessing Risks
for Health Hazards: An Imperfect Science, 3 Tech. Rev. 60 (1986); Von Winterfelt, Four
Theses on the Application of Risk Assessment in Relation to Environmental Mutagens and
Carcinogens, in Risk and Reason: Risk Assessment in Relation to Environmental Mutagens and
Carcinogens (P. Oftedal & A. Brogger, eds. 1986); Richard Wilson & W. Clark, Risk
Assessment and Risk Management: Separation Does Not Mean a Divorce, in Proceedings of
the 1988 Annual Meeting of the Society for Risk Analysis).
22 The January 1998 Wingspread Statement on the Precautionary Principle states: "\vhen an
activity raises threats of harm to human health or the environment, precautionary measures
should be taken even if some cause-and-effect relationships are not fully established
scientifically." See Tickner & Raffensperger, supra n. 8, at 1.
23 When speaking of acceptable levels of potentially dangerous toxicological hazards,
Precautionary Principle advocates are interested primarily in the cumulative and synergistic
effects on ecological systems. This often translates into significantly more stringent standards
than, say, conducting a traditional quantitative risk assessment addressing only acute or chronic
effects of substance.
24 See Tickner & Raffensperger, supra n. 8.
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interim period include bans and phase-outs, alternatives assessment,
extremely conservative health-based occupational exposure limits,
prima facie reverse onus chemical listing, and ecosystem management
policies that ensure reversibility and flexibility.
These actions are designed to function immediately and for the
most part, autonomously, from the need for scientific certainty. In fact,
the onus of responsibility is placed on uncertainty as the operative
phenomenon in which to gauge our assumptions of toxicological
hazards. Such actions are almost exclusively focused on public health
and rarely take into consideration economic and political stressors.
Ozonoff articulates the concern of using only a precautionary approach
for screening potential risks because such an approach, although
increasing our sensitivity to predicting such threats, inadvertently takes
an overly precautious stand when it is unnecessary. 25 Such an attitude
is resource intensive and time-consuming, thus in many fundamental
ways negating the primary purpose of a precautionary approach. Even
precautionary action advocates who are willing to accept the
incorporation of uncertainty (albeit quantified) into toxicological risk
assessments through the use of model sensitivity analyses (e.g., Monte
Carlo Simulations) are still faced with the daunting time consuming
needs of collecting large enough databases for calculations. And as with
any mathematical model, the results are only as good as the
assumptions, and the choice of assumptions, particularly simplifying
ones, is not always possible or heavily relies on the professional
judgment (normative biases) of the assessor. The greater complexity
also presents a significant challenge to effectively incorporating the
public in the decisionmaking matrix during the interim phase (a key
normative consideration for the Precautionary Principle).26
For the most part, bans and other immediate actions are politically
dangerous and unacceptable in either a postmarket or premarket setting
where economic and social investment issues are of critical importance.
There is a fear of stifling production especially when no, or very litde,
causal (or correlative) proof of toxicological danger exists. Plus, most of
25 See David Ozonoff, The Precautionary Principle as a Screening Device, in Protecting
Public Health and the Environment: Implementing the Precautionary Principle (Carolyn
Raffensperger & Joel Tickner eds., 1999).
26 See Susan R. Poulter, Monte Carlo Simulation in Environmental Risk Assessment:
Science, Policy and Legal Issues, 9 Risk: Health, Safety & Environment 7 (1998).
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these actions are implausible because of the pervasive globalized use of
some chemical substances (e.g., DDT).
Furthermore, such a drastic call to arms usually spurs political
dissent, creating a hostile policy environment in which to negotiate
alternative actions. This in turn raises legal concerns since most
precautionary actions usually require some type of juridical intervention
and support. The interface between science and law is a tenuous one at
that, prone to misinterpretation and stagnation. Essentially, a
procedural and statutory bias exists, often favoring preexisting
operational practices of a possibly polluting activity. 27
Even if precautionary actions are successfully initiated, they can be
as time consuming as the original risk assessment. In fact, one could
argue that ascertaining scientifically valid evidentiary data plus
acquiring precautionary default limits while simultaneously addressing
chronic toxicity and conducting a technology options assessment, as
well as facilitating a meaningful open democratic dialogue between all
stakeholders, would require even more time and resources than
traditional quantitative risk assessment.
Scientists in a precautionary approach are members in a cooperative,
multidisciplinary, problem-solving community, a community
composed of ethicists, legislators, lawyers, labor and business
representatives. A precautionary approach is a holistic undertaking that
transcends traditional scientific boundaries. Peer review is an inclusive
endeavor, drawing from a vast range of expertise in addressing an issue.
Because a precautionary approach takes a long-range point of reference
to human impacts on environmental health, and due to methodological
and ethical complexities of such a temporal and geographical
perspective, authentic problem-solving techniques are beyond the scope
of any single scientific discipline. Shrader-Frechette and McCoy argue
that isolated scientific disciplines' research methods, theories, and
empirical bases in ecology are "underdetermined," and thus cannot
provide a foundation for effective environmental policy formulation. 28
27 See Carl F. Cranor, Asymmetric Information, the Precautionary Principle, and Burdens
of Proof, in Protecting Public Health and the Environment: Implementing the Precautionary
Principle (Carolyn Raffensperger & Joel Tickner eds., 1999).
28 See Kristin Shrader-Frechette & Earl D. McCoy, Method in Ecology. Strategies for
Conservation (Cambridge U. Press 1993).
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Thus, Barrett and Raffensperger conclude, "For such reasons, scientists
must participate in research that is multidisciplinary (e.g., incorporates
social sciences), multilevel (e.g., considers networks and relationships),
and community based (e.g., includes many different value
judgments)."29 Essentially, by itself, a top-down, holistic approach to
toxicological risk assessment is a time consuming and expensive
endeavor fraught with political and social tension. Given the inherent
limits of precautionary actions operating autonomously, an alternative
approach or process is necessary to co-exist beside a precautionary
attitude that will effectively ensure public health and ecological stability
while still juggling all stakeholder interests and facilitating an open,
democratic forum in which to allow relevant voices to be heard during
the interim phase of a risk assessment.
Short-Term Tests: Effectively Integrating Risk Assessment and
Precautionary Attitudes
Currently, EPA intentionally uses default options intended to yield
health-protective risk estimates absent sufficient data or resources to
characterize each risk-assessment parameter accurately. Using an
iterative approach to toxicological screening, lower-tier assessments can
be used for preliminary screening relying heavily on pre-determined
default options. Results of such screening support conservative, health-
protective exposure limits.
If a lower-tier risk assessment indicates that an unacceptable health
risk could be associated with a particular exposure or a regulated party
believes that the risk has been overestimated, a higher-tier risk
assessment can be performed. Instead of relying on default parameters,
higher-tiered risk assessments use more precise technology, which is
more time consuming and expensive but provides more accurate
information. "Conversely, if EPA believes that a lower-tier risk
assessment has underestimated the health risk associated with a
particular exposure, a higher-tier risk assessment might yield a more
reliable estimate." 30
29 Katherine Barrett & Carolyn Raffensperger, Precautionary Science, in Protecting Public
Health and the Environment: Implementing the Precautionary Principle 115 (Carolyn
Raffensperger & Joel Tickner eds., 1999).
30 See Committee on Risk Assessment of Hazardous Air Pollutants, supra n. 1, at 247.
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By incorporating an iterative toxicity-screening paradigm through
the use of lower-tiered testing procedures, testing times for carcinogen
potency assessments, for example, could be dramatically reduced.
Taking anywhere between 0.5 to 5 person years per substance,
traditional carcinogen potency assessments using animal bioassays,
although amazingly accurate, consume vast quantities of time and
resources. 3 1 The animal bioassay for carcinogenic detection is very
complex and very expensive scientific study, usually involving hundreds
of rodents, which must be dosed with the test chemical for most of
their lives. Unfortunately, because of these time-constraints, in the last
century, uncounted multitudes of chemicals have been introduced into
the environment with hundreds more being synthesized and distributed
every year with only an alarmingly small percentage being tested with
conventional animal studies.
Even as late as 1994, EPA's inventory of regulable chemicals under
TSCA exceeded 72,000 substances, most of which had not been
evaluated for basic toxicity screening. 32 With an ever-widening net of
chemicals being brought into global production and distribution every
year, traditional testing methods are just too time consuming and
expensive to keep up with demand. With limited resources and budget,
coupled with the financial burdens of conducting toxicological risk
assessments, EPA's selective enforcement policy facilitates a less than
lack-luster motivation for private industry to thoroughly evaluate the
safety of their chemical products before they are released into the
public.
For instance, the recent debate surrounding Methyl Tertiary Butyl
Ether (MTBE), a fuel oxygenate in use since the mid-i 970s, illuminates
the dire importance for interim assessment. Heavily tested for human
health effects relating to inhalation and air quality, MTBE underwent
almost no testing to determine its effect on aquatic ecosystems and
drinking water. Lacking sufficient data, both EPA and the National
Science and Technology Council in 1997 reported they could not
adequately estimate potential acute or chronic health risks of MTBE at
low exposure levels in drinking water, even though it is widely known
31 See Cranor, supra n. 9.
32 General Accounting Office, GAO Report, B-256039, Toxic Substances Control Act:
Legislative Changes Could Make the Act More Effective 2 (1994).
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that MTBE is a human carcinogen. 33 Created to redress a public
health hazard, MTBE itself inadvertently became a public health hazard
precisely because of inadequate and non-holistic interim risk
characterization and exposure analysis.
This lack of interim testing constitutes a major environmental and
human health problem. When EPA began ranking human health risks
associated with occupational exposures, pesticide residues, and
hazardous waste sites, EPAs analysis was marred by the lack of
assessments available for study. In fact, most state agencies rely on
occupational exposure limits for screening and regulating toxic sources,
which often lack threshold levels for toxic effects, and unfortunately,
rarely are health-based. Even more troubling is that different agencies,
operating with different datasets and regulatory schemas that generate
different, and at times, contradictory sets of guidelines, many for the
same compounds. 34
For these reasons, the last several decades have seen a rise in the
number of relatively cheap and rapid tests for detecting mutagenic and
carcinogenic chemicals. Known as Short Term Tests (STTs), these
procedures are economical resources that can function as screening
devices capable of producing usable data usually in a matter of weeks.
Most of these STTs are based on the demonstration of chromosomal
damage, gene mutations, or DNA damage, with many of them being
in vitro assays, meaning they are conducted in experimental biological
systems without the use of live animals. The test organisms range from
bacteria and yeasts to insects, plants, and cultured animal cells. In some
instances, laboratory animals are exposed to test chemicals from periods
typically ranging from a couple of hours to several weeks. 35
33 Committee on Environment and Natural Resources, National Science and Technology
Council, Interagency Assessment of Oxygenated Fuels (June 1997).
34 Sara M. Hoover et al., Improving the Regulation of Carcinogens by Expediting Cancer
Potency Estimation, 15 Risk Analysis 2 (1995) (citing Science Advisory Board, The Report of
the Human Health Subcommittee: Relative Risk Reduction Project (EPA SAB-EC-90-021B,
Washington, DC, 1990); S.T. Dydek, Comparison of Health Risk Assessment Approaches for
Carcinogenic Air Pollutants, Presented at 82nd AWMA Annual Meeting, Anaheim, CA
(1989); Edward Calabrese & Elaina Kenyon, The Perils of State Air Toxics Programs, 23
Environmental Science and Technology, 1323 (1989)).
35 See International Commission for Protection Against Environmental Mutagens and
Carcinogens, Guide to Short-Term Tests for Detecting Mutagenic and Carcinogenic
Chemicals, a report prepared for the International Programme on Chemical Safety, World
Health Organization, Geneva, 1985.
12 Risk: Health, Safety & Environment 281 [Fall 2001]
Although less accurate than traditional testing methods, many
STTs are sufficiently accurate for lower-tier hazard identification
purposes. In fact, modeling procedures similar to those used by
environmental economists suggest that even STTs that are less than
fully accurate, with false positive rates above 0.05, may have uses both
in premarket and in postmarket regulation situations. 36 Bacterial
bioassays STTs, which are the most extensively studied and validated
type of STT, have in one study given a predictive value for carcinogenic
potential of about 90%.3 7 For instance, a well-known bacterial
(Salmonella) assay can screen chemicals for potential mutagenicity and
carcinogenicity, as well as map mechanisms of toxic action, by
evaluating a compound's ability to mutate DNA.38
STTs are not designed nor should be used for estimating the risk of
a potential carcinogenic substance. Since STTs are less accurate and are
prone to unique constraints, often because of their simplicity in design
and use, STTs should be used in a series of "batteries," allowing for an
opportunity to correlate and compare results through several trials.3 9
As stated earlier, the question of quantifying risk is already an uncertain
business, dependent upon many factors. Data gained from screening
tests, such as STTs, cannot be used as the sole basis for predicting the
potency of the carcinogenic activity in the environment or in humans.
STTs merely act as preliminary indicators, pointing out which
substances ought to receive priority for further, more extensive study.
Nevertheless, STTs still offer significant advantages over the
traditional toxicological risk assessment paradigm. Lists of potentially
toxic substances based on STTs could be used by academic institutions
to help redress data gaps, expand the number of research institutes
36 See Talbot Page, A Framework of Unreasonable Risk in the Toxic Substances Control
Act, in Annals of the New York Academy of Science: Management of Assessed Risk for
Carcinogens 145 (William J. Nicholson ed., 1981). See also Lester Lave & Gilbert S. Omenn,
Cost-Effectiveness of Short-Term Tests for Carcinogenicity, 324 Nature 29 (1986).
37 See J. McCann & Bruce N. Ames, Detection of Carcinogens as Mutagens in the
SalmonellalMiicrosome Test: Assay of 300 Chemicals, 75 Proc. Nat. Acad. Sci. 5135 (1975);
Evaluation of Short-Term Tests for Carcinogens (F. J. De Serres & J. Ashby, eds.,
(198 1)(Progress in Mutation Research, Vol.1).
38 E. Zeiger, Mutagenicity Tests in Bacteria as Indicators of Carcinogenic Potential in
Mammals, in Environmental Mutagenesis 107-19 (D. H. Phillips & S. Venitt eds., 1995).
39 See International Commission for Protection Against Environmental Mutagens and
Carcinogens, supra n. 35.
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because of lower costs associated with testing, as well as confirm or
refute preliminary toxicity data from industry or government
sources. 40 STTs could be used by public watchdog organizations, or
by industry itself, to quickly assess the potential carcinogenic properties
associated with a particular substance.
In a regulatory context, STTs could be mobilized in an iterative
testing paradigm, as a lower-tiered screening program, to trigger more
expensive and time-consuming risk assessments. This would allow for
more streamlined regulatory hurdles, increasing industry compliance
and accountability. STTs create market-based incentives for improved
product performance by providing for greater regulatory transparency
and accountability, broadening the number of third party testing
agencies, and increasing the potential frequency of governmental audits
of a company's compliance performance.
There are also unique social and ethical advantages to using STTs,
particularly when discussing issues regarding research conducted on
laboratory animals. Public concern about animal use in the past several
decades has resulted in the enactment of several legislative mandates
requiring scientists to consider, prior to in vivo research, alternatives that
either do not use animals, significantly reduce the number used, or
minimize pain and distress. 41 Currently there are a series of alternative
in vitro cytotoxicity tests that show promise of either replacing or
reducing rodent acute oral toxicity tests for determining LD50 values.
If properly developed and refined, such in vitro methods could
ultimately replace the use of laboratory animals in acute lethality
tests.42 For instance, a recent National Institutes of Health report cites
a previous study describing the Limulus Amebocyte Lysate test, a time
and cost-saving in vitro method using blood cells from horseshoe crabs,
which has replaced rabbit pyrogenicity testing to detect endotoxins.43
40 See Cranor, supra n. 27.
41 Such legislation includes Animal Welfare Act., Pub. L. No. 99-198; Health Research
Extension Act of 1985, Pub. L. No. 99-158; NIH/Naional Institutes of Health Revitalization
Act, Pub. L. No. 103-43.
42 National Institute of Environmental Health Sciences, Report of the International
Workshop on In Vitro Methods for Assessing Acute Systemic Toxicity, National Institutes of
Health (NIH) Publication No. 01-4499, 29 (2001).
43 NIEHS (National Institute of Environmental Health Sciences), Validation and Regulatory
Acceptance of Toxicological Test Methods: A Report of the ad hoc Interagency Coordinating
Committee on the Validation of Alternative Methods, NIH Publication No. 97-3981
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Although this is probably unlikely in the foreseeable future, many in
vivo STTs can use phylogenetically lower organisms such as fish,
invertebrates, and algae, to test for environmental effects in assessing
ecotoxicity, as well as potential carcinogenic danger, of many
ubiquitous chemicals.
Furthermore, expedited potency assessments, which are often
procedural programs designed to increase the efficiency of risk
assessments, can also function much like STTs. For instance, the
Linearized Multistage Default Method (LMS), utilizing the
Carcinogenic Potency Database (CPDB) created by Lois Gold et
al.44 , streamlines several procedural actions and facilitates several tasks
that under traditional risk assessments are extremely time
consuming. 45 Through LMS paradigm potency, values are quickly
estimated using default risk extrapolation procedures adopted by EPA
and CEPA (California Environmental Protection Agency). CEPA used
LMS to estimate the carcinogen potency for 200 agents in an eight-
month time period (compared to only 70 in the previous five years) as
part of California's enforcement of its Proposition 65 (Safe Drinking
Water and Toxic Enforcement Act of 1986).46 Had traditional
science-intensive carcinogen potency assessments been used on the same
200 agents, the cost would have been between $7 million and $70
million. As it stands, the use of LMS reduced this estimated cost to a
mere $4,000.47
As illustrated by LMS and other testing procedures, STTs provide
inherent advantages over traditional approaches to risk assessment or
strict precautionary action. In fact, when used in an iterative interim risk
characterization program, STTs bridge the gap between the normative
and social responsibilities of conducting a toxicological risk assessment
(1997)(citing Oliver P. Flint, A timetable for replacing, reducing and refining animal use with
the help of in vitro tests: The Limulus Amebocyte Lysate Test (LAL) as an example, in
Alternatives to Animal Testing: New Ways in the Biomedical Sciences, Trends and Progress
27-43 (C.A. Reinhardt ed., (1994)).
44 Lois Swirsky Gold et al., A Carcinogenic Potency Database of the Standardized Results
of Animal Bioassays, 58 Envtl. Health Persp. 9 (1984).
45 See Hoover et al., supra n. 34.
46 Reproductive and Cancer Hazard Assessment Section, California Environmental
Protection Agency, Expedited Cancer Potency Values and Proposed Regulatory Levels for
Certain Proposition 65 Carcinogens (1992) (cited in Cranor, supra n. 27).
47 See Cranor, supra n. 9, at n. 10.
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and the necessity of upholding a "sound science" approach to accurately
determining the potential threat of a substance. Because STTs still
operate within the "scientific paradigm," they require less of a
pragmatic and theoretical confrontation between traditional risk
assessment adherents and Precautionary Principle advocates. STTs used
during the interim phase of a risk assessment are not meant as definitive
statements of the toxicological danger of substance, but rather act only
as preliminary indicators warning of a potential public health or
ecological hazard.
In conclusion, conceiving of risk assessment, in part, as a mechanism
for protecting public health and environmental safety, opens up the
possibility of different evidentiary approaches for different informal
and regulatory purposes-just as we otherwise demand different kinds
and amounts of evidence in different social and legal contexts.4 8 A
greater onus should be placed on creating and implementing STTs in
conjunction with a precautionary attitude during the interim phase of
toxicological risk assessments that use iterative, conservative, tiered
procedures. In this way, social costs will be minimized, while the
scientific and normative rigor necessary to validate conclusions will be
preserved. And in this way, the process will remain flexible enough to
incorporate uncertainty and public input into the matrix of protecting
public health and ecological integrity.
48 Id.
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